Healthcare -
Biotechnology - NASDAQ - US
$ 4.525
-6.7 %
$ 252 M
Market Cap
-2.45
P/E
FHTX - CAPITAL EXPENDITURES
Capital Expenditures FHTX - Foghorn Therapeutics Inc.
-1.22 M
LAST VALUE
39.22%
2 YEAR CAGR
4.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR